New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 11, 2017 – Intersect ENT announced the FDA approval of Sinuva (mometasone furoate) sinus implant, for the treatment of nasal polyps in patients ≥ 18 years of age who have had ethmoid sinus surgery.
Download PDF
Return to publications